Companies › OPTIC
OPTIC logo

OPTIC

San Francisco, California, USA · ≈300 employees · Research and Development in Biotechnology (except Nanobiotechnology) · bioptic.io

BIOPTIC is a private life sciences and biotechnology company that specializes in AI-driven research services for the pharmaceutical industry. It provides an AI platform designed to assist pharma teams and life sciences investors in evaluating drug opportunities from evidence gathering to competitive analysis and launch planning. By consolidating fragmented pharma data, BIOPTIC aims to streamline research processes, turning multi-week cycles into faster, structured outputs. The company offers a range of services, including asset scouting, competitive intelligence, due diligence, launch planning, and custom research. Its approach combines specialized AI agents with expert reviews from pharma professionals, ensuring that clients receive comprehensive and actionable insights. BIOPTIC operates from locations in San Francisco and Dubai, and its clients include teams from Big Pharma, biotech firms, and life sciences investment funds.

Also: biotechnology research · curated pharma data · pharma-specific data · ai automation · ligand-based models · molecular discovery · deal prioritization · multi-language patent scanning · vertical ai agents · data infrastructure · ai for biotech · diligence automation

Funding

0
Every round, secondary, debt facility or acquisition involving OPTIC that AI Lounge tracks, newest first.
No rounds recorded yet.

Timeline · 2

In the news

2
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in